Press Releases

and/or
571 News Releases found
Philip Paty
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon.
Dr. Charles Sawyers
Charles Sawyers, MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center and a Howard Hughes Medical Institute investigator, has been named a "Dream Team" leader by Stand Up To Cancer and will co-lead a collaborative team that will receive $15 million to study targeted therapies to treat women's cancers.
Picture: Joan Massagué
New research led by investigators at Memorial Sloan Kettering Cancer Center identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs.
Charles Sawyers, MD
A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.
Media Advisory
Researchers at Memorial Sloan Kettering Cancer Center have shown for the first time that a tendency to develop some blood disorders may be inherited.
 Dr. Tim A. Ahles
The National Institutes of Health's National Cancer Institute has awarded The City College of New York and Memorial Sloan Kettering Cancer Center a $15.9 million grant to implement a unique partnership in cancer research, education, and outreach.
A doctor at MSK
The majority of young women at an increased risk of breast cancer due to chest radiation treatment for childhood cancer are not following breast cancer screening recommendations, according to a recently released, detailed assessment appearing in the January 28, 2009, issue of the <I>Journal of the American Medical Association</I>.
Peter B. Bach, MD, MAPP
Media Advisory
A new health policy report which will be published in the New England Journal of Medicine suggests that the swift and dramatic rise in cancer-drug spending is due to laws that keep Medicare from managing the use or price of cancer drugs. These laws limit Medicare's actions in cancer far more than they are limited in other areas of healthcare.
Stephen Nimer, MD
A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study's findings, researchers identified the genetic pathway used to maintain a cell's quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.
Michelle S. Bradbury
Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.